Publikationen von Matthias L. Schroeter

Dukart, J.; Müller, K.; Horstmann, A.; Barthel, H.; Möller, H. E.; Villringer, A.; Sabri, O.; Schroeter, M. L.: Combined evaluation of FDG-PET and MRI improves detection and differentiation of dementia. PLoS One 6 (3), e18111 (2011)

Steiner, J.; Bogerts, B.; Schroeter, M. L.; Bernstein, H.-G.: S100B protein in neurodegenerative disorders. Clinical Chemistry and Laboratory Medicine 49 (3), S. 409 - 424 (2011)

Mueller, K.; Mildner, T.; Fritz, T. H.; Lepsien, J.; Schwarzbauer, C.; Schroeter, M. L.; Möller, H. E.: Investigating brain response to music: A comparison of different fMRI acquisition schemes. NeuroImage 54 (1), S. 337 - 343 (2011)

Schroeter, M. L.; Steiner, J.; Mueller, K.: Glial pathology is modified by age in mood disorders - A systematic meta-analysis of serum S100B in vivo studies. Journal of Affective Disorders 134 (1-3), S. 32 - 38 (2010)

Raczka, K. A.; Becker, G. A.; Seese, A.; Frisch, S.; Heiner, S.; Marschhauser, A.; Barthel, H.; Scheid, R.; Sabri, O.; Schroeter, M. L.: Executive and behavioral deficits share common neural substrates in frontotemporal lobar degeneration - A pilot FDG-PET study. Psychiatry Research: Neuroimaging 182 (3), S. 274 - 280 (2010)

Dukart, J.; Müller, K.; Horstmann, A.; Vogt, B.; Frisch, S.; Barthel, H.; Becker, G.; Möller, H. E.; Villringer, A.; Sabri, O. et al.; Schroeter, M. L.: Differential effects of global and cerebellar normalization on detection and differentiation of dementia in FDG-PET studies. NeuroImage 49 (2), S. 1490 - 1495 (2010)

Horstmann, A.; Frisch, S.; Jentzsch, R. T.; Müller, K.; Villringer, A.; Schroeter, M. L.: Resuscitating the heart but losing the brain: Brain atrophy in the aftermath of cardiac arrest. Neurology 74 (4), S. 306 - 312 (2010)

Schroeter, M. L.; Abdul-Khaliq, H.; Sacher, J.; Steiner, J.; Blasig, I. E.; Müller, K.: Mood disorders are glial disorders: Evidence from in vivo studies. Cardiovascular Psychiatry and Neurology 2010, 780645 (2010)

Schroeter, M. L.; Ettrich, B.; Menz, M. M.; Zysset, S.: Traumatic brain injury affects the frontomedian cortex: An event-related fMRI study on evaluative judgments. Neuropsychologia 48 (1), S. 185 - 193 (2010)

Steiner, J.; Myint, A. M.; Schiltz, K.; Westphal, S.; Bernstein, H.-G.; Walter, M.; Schroeter, M. L.; Schwarz, M. J.; Bogerts, B.: S100B serum levels in schizophrenia are presumably related to visceral obesity and insulin resistance. Cardiovascular Psychiatry and Neurology 2010, S. 480707 (2010)

Steiner, J.; Schiltz, K.; Walter, M.; Wunderlich, M. T.; Keilhoff, G.; Brisch, R.; Bielau, H.; Bernstein, H.-G.; Bogerts, B.; Schroeter, M. L. et al.; Westphal, S.: S100B serum levels are closely correlated with body mass index: An important caveat in neuropsychiatric research. Psychoneuroendocrinology 35 (2), S. 321 - 324 (2010)

Steiner, J.; Schroeter, M. L.; Schiltz, K.; Bernstein, H.-G.; Müller, U.; Richter-Landsberg, C.; Müller, W.; Walter, M.; Gos, T.; Bogerts, B. et al.; Keilhoff, G.: Haloperidol and clozapine decrease S100B release from glial cells. Neuroscience 167 (4), S. 1025 - 1031 (2010)

Steiner, J.; Walter, M.; Guest, P.; Myint, A. M.; Schiltz, K.; Panteli, B.; Brauner, M.; Bernstein, H.-G.; Gos, T.; Herberth, M. et al.; Schroeter, M. L.; Schwarz, M. J.; Westphal, S.; Bahn, S.; Bogerts, B.: Elevated S100B levels in schizophrenia are associated with insulin resistance. Molecular Psychiatry 15 (1), S. 3 - 4 (2010)

Schroeter, M. L.; Stein, T.; Maslowski, N.; Neumann, J.: Neural correlates of Alzheimer's disease and mild cognitive impairment: A systematic and quantitative meta-analysis involving 1,351 patients. NeuroImage 47 (4), S. 1196 - 1206 (2009)

Jourdan Moser, S.; Cutini, S.; Weber, P.; Schroeter, M. L.: Right prefrontal brain activation due to stroop interference is altered in attention-deficit hyperactivity disorder - A functional near-infrared spectroscopy study. Psychiatry Research 173 (3), S. 190 - 195 (2009)

Schroeter, M. L.; Abdul-Khaliq, H.; Krebs, M.; Diefenbacher, A.; Blasig, I. E.: Neuron-specific enolase is unaltered whereas S100B is elevated in serum of patients with schizophrenia – Original research and meta-analysis. Psychiatry Research 167 (1-2), S. 66 - 72 (2009)

Scheid, R.; Frisch, S.; Schroeter, M. L.: Superficial siderosis of the central nervous system - Treatment with steroids? Journal of Clinical Pharmacy and Therapeutics 34 (5), S. 603 - 605 (2009)

Schroeter, M. L.; Steiner, J.: Elevated serum levels of the glial marker protein S100B are not specific for schizophrenia or mood disorders. Molecular Psychiatry 14 (3), S. 235 - 237 (2009)

Scheid, R.; Jentzsch, T.; Schroeter, M. L.: Cognitive dysfunction, urinary retention, and a lesion in the thalamus - beware of possible toxocariasis of the central nervous system. Clinical Neurology and Neurosurgery 110 (10), S. 1054 - 1057 (2008)

Scheid, R.; Teich, N.; Schroeter, M. L.: Aerophagia and belching following Herpes simplex encephalitis. Cognitive and Behavioral Neurology 21 (1), S. 52 - 54 (2008)